Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-23
2007-01-23
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S247000, C514S256000, C514S277000, C514S357000, C514S364000, C514S398000, C514S408000, C544S106000, C544S224000, C544S242000, C546S329000, C546S339000, C548S131000, C548S335100, C548S400000
Reexamination Certificate
active
10721318
ABSTRACT:
The present invention provides non-steroidal compounds of formula I which are selective modulators (i.e., agonist and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides pharmaceutical compositions containing these compounds and methods for using these compounds to treat animals requiring glucocorticoid receptor agonist or antagonist therapy. Glucocorticoid receptor modulators are useful to treat diseases, such as obesity, diabetes, inflammation and others as described below. The present invention also provides intermediates and processes for preparing these compounds
REFERENCES:
patent: 3516993 (1970-06-01), Houlihan et al.
patent: 3683091 (1972-08-01), Nagata et al.
patent: 5039706 (1991-08-01), Wilkerson
patent: 5696127 (1997-12-01), Jones et al.
patent: 5767113 (1998-06-01), Cohn et al.
patent: 6380223 (2002-04-01), Dow et al.
patent: 6699893 (2004-03-01), Dow et al.
patent: 0188396 (1986-07-01), None
patent: 0683172 (1995-11-01), None
patent: 0903146 (1999-03-01), None
patent: 11139/70 (1970-04-01), None
patent: 4514056 (1970-05-01), None
patent: 4536500 (1970-11-01), None
patent: 83138/86 (1986-04-01), None
patent: 271216/86 (1986-12-01), None
patent: 56422/87 (1987-03-01), None
patent: 6263688 (1994-09-01), None
patent: 9052899 (1997-02-01), None
patent: WO 95/10266 (1995-04-01), None
patent: WO 98/26783 (1998-06-01), None
patent: WO 98/27986 (1998-07-01), None
patent: WO 98/31702 (1998-07-01), None
DiMaio et al, Can. J. Chem. vol. 62, pp. 2697-2701, 1984.
Chemical Abstracts, vol. 108, Abstract No. 67,094, 1988.
Basu, et al, Tetrahedron Letters, vol. 25, No. 11, pp. 1195-1196, 1984.
Matsumoto et al, Tetrahedron Letters, vol. 9, pp. 1127-1131, 1968.
Turner et al, J. Am. Chem. Soc, vol. 88, pp. 1786-1792, 1966.
Saha, Synthetic Communications, vol. 23, No. 13, pp. 1821-1828, 1993.
J.A. Findlay et al., “Synthesis in the Diterpene Alkaloid Series-I The Stereospecific Synthesis of an Intermediate and its Identification with a Natural Degradation Product”,Tetrahedron Letters, No. 19:869-872 (1962).
E. Fujita et al., Terpenoids. Part XXVIII.sup. 1 Total Synthesis of Enmein.sup.2.,J. Chem. Soc., Perkin Trans. I, (1):165-177 (1974).
P.N. Chakrabortty et al., “Sythetic Studies in Resin Acid Series: Part VII*-Synthesis of 1α-Methyl-1β, 4αβ-dicarboxy-1,2,3,4,4a,9,10,10αβ-octahydrophenanthrene & 1β, 4αβ-Dicaroboxy-1,2,3,4,4a,9,10,10aα octahydrophenanthrene”,Indian J. Chem., 12(9):945-955 (1974).
U.R. Ghatak et al., “Angular Alkylation Through a Novel Intramolecular Cationic Reaction. A Simple Sterospecic Route to Polycyclic Bridged-Ring Intermediates Towards Some Complex Diterpenoids”,Tetrahedron Letters, No. 32:2929-2931 (1978).
G. Sinha et al., “Condensed Cyclic and Bridged-ring System. Part 9.sup.1 Sterocontrolled Sythesis and X-Ray Structural Analysis of cis-3,4,4a,9,10,10a-Hexahydro-1,4a-ethanophenanthrene-2-(1H),12-dione and trans-3,4,4a,9,10,10a,-Hexahydro-3,4a-ethanophenanthrene-2(1H), 12-dione”,J. Chem. Soc., Perkin Trans.I, (10):2519-2528 (1983).
P.R. Kanjilal et al., “Synthetic Studies Toward Complex Diterpenoids. 16.sup.1. A Novel Synthetic Route to the Carbocyclic Skeleta of Stemodin and Stemarin by Acid-Catalyzed Intramolecular C-Alkylation and Rearrangement Reactions”,J. Org. Chem., (50):857-863 (1985).
C.F. Biggs et al., “Synthesis and Pharmacological Evaluation of 4a-Phenanthrenamine Derivatives Acting at the Phencyclidine Binding Site of the N-Methyl-D-Aspartate Receptor Complex”,J. Med. Chem., (36):1977-1995 (1993).
H. Sdassi et al., “Enantioselective Synthesis of (R)-(+)-4a-Cyanomethyl-6-Methoxy-3,4,9,10-Tetrahydrophenanthren-2-One”,Synthetic Communications, 25(17):2569-2573 (1995).
D. Bonnet-Delpon et al., “Trifluoromethylalkenes in Cycloaddition Reactions#”,Tetrahedron, 52(1):59-70 (1996).
T. Ibuka et al., “Studies on the Alkaloids of Menispermaceous Plants. CCXXXVI.*sup.3”, 87(8):1014-1017 (1967)-English-Language Translation.
Chemical Abstracts, 84(19), Columbus, Ohio, US; abstract No. 135496w, Kigasawa et al.: “1,2-Cycloalkanoisoquinolines” and JP 50 111098-(Grelan Pharmaceutical Co., Ltd.; Japan) (1976).
Lee, Y., et al., Heterocycles,Studies on the Site-Selective N-Acyliminium Ion Cyclization: Synthesis of(±)-Glochidine and(±)-Glochidicine, vol. 37, No. 1, 1994, 303-309.
Baba, Y., et al., Terahedron,Alternative Synthetic Approaches to(±)-Euryfruan via The Furan Ring Transfer Reaction, vol. 50, No. 19, 1994, 5645-5658.
Boatman, S., et al., Journal of the American Chemical Society,Alkylations at the α′-Methylene or Methinyl Group of α-Formyl Cyclic Ketones through Their Dicarbanions. Angular Alkylations1,, 87:1, 1965, 82-86.
Tius, M., et al., Tetrahedron Letters,Aromatic Annelation. A Synthese of(±)-3-Methyl-8, 14-Dehydromorphinan, vol. 27, No. 38, 1986, 4541-4544.
Saha, B., et al, Tetrahedron Letters,A Novel Synthetic Method for Angularly Functionalized Polycyclic Systems by Vinylogous Wolff Rearrangement of β,γ-Unsaturated Diazoketones, vol. 27, No. 33, 1986, 3913-3914.
Hegarty, P., et al, Tetrahedron, A New Approach to the Skeletons of Both the Aphidicolin and Stemodin Diterpenoids, vol. 51, No. 33, 1995, 9079-9090.
Patil, D., Journal of Chemical Society,C-Aromatic Steroids. Synthesis of 11,17E-Dimethoxy-18-norandrosta-4,8,11,13-tetraen-3-one, 1982, No. 1, 201-204.
Kobayashi, K., et al, Int. J. Biochem.,Effect of Pisiferic Acid and Its Derivatives on Cytotoxicity Macromolecular Synthesis and DNA Polymease a of HeLa Cells, vol. 21, No. 5, 1989, 463-468.
Dow Robert L.
Liu Kevin K.
Morgan Bradley P.
Swick Andrew G.
Ashbrook Charles
Boss Brandon S.
Davis Zinna N.
Pfizer Inc.
LandOfFree
Glucocorticoid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucocorticoid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3791471